Nuvalent (NUVL) Cash & Equivalents (2020 - 2026)

Nuvalent (NUVL) posted Cash & Equivalents of $159.7 million for Q1 2026, down 38.97% on a QoQ basis from $261.7 million in Q4 2025, and up 32.19% year-over-year from $120.8 million in Q1 2025.

Nuvalent (NUVL) Cash & Equivalents (2020 - 2026) Analysis & Trends

Nuvalent's Cash & Equivalents history runs 7 years deep, the most recent figure standing at $159.7 million for Q1 2026.

  • Quarterly Cash & Equivalents rose 32.19% year-over-year to $159.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $159.7 million (up 32.19% YoY) and the FY2025 annual result came in at $261.7 million, up 79.66% from the prior year.
  • Cash & Equivalents was $159.7 million for Q1 2026 at Nuvalent, down from $261.7 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $369.2 million in Q3 2024 and bottomed at $67.3 million in Q1 2022.
  • A 5-year average of $158.0 million and a median of $120.8 million in 2025 frame the typical range for Cash & Equivalents.
  • Annual changes were most pronounced in 2024 — Cash & Equivalents surged 317.54% — and 2025, when it slumped 68.65%.
  • Nuvalent's Cash & Equivalents stood at $241.8 million in 2022, then jumped by 38.7% to $335.4 million in 2023, then slumped by 56.56% to $145.7 million in 2024, then jumped by 79.66% to $261.7 million in 2025, then sank by 38.97% to $159.7 million in 2026.
  • Business Quant data shows NUVL's Cash & Equivalents at $159.7 million in Q1 2026, $261.7 million in Q4 2025, and $115.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 82.45 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 61.40 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 4.79 Bn
4 NuCana 279.75 Bn 279.75 Bn - 32.26 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 5.49 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 2.96 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 3.58 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 440.94 Mn
10 Nuvalent 9.75 Bn 9.75 Bn - 159.73 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 159.73 Mn
Dec 31, 2025 261.75 Mn
Sep 30, 2025 115.75 Mn
Jun 30, 2025 127.47 Mn
Mar 31, 2025 120.84 Mn
Dec 31, 2024 145.69 Mn
Sep 30, 2024 369.24 Mn
Jun 30, 2024 77.70 Mn
Mar 31, 2024 98.52 Mn
Dec 31, 2023 335.39 Mn
Sep 30, 2023 88.43 Mn
Jun 30, 2023 70.87 Mn
Mar 31, 2023 90.12 Mn
Dec 31, 2022 241.81 Mn
Sep 30, 2022 239.06 Mn
Jun 30, 2022 75.92 Mn
Mar 31, 2022 67.27 Mn
Dec 31, 2021 68.53 Mn
Sep 30, 2021 245.89 Mn
Dec 31, 2020 10.33 Mn